We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

68 hedge funds and large institutions have $22.6M invested in Genesis Healthcare, Inc. in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 7368 (-5)

33% less capital invested

Capital invested by funds: $33.8M → $22.6M (-$11.2M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
68
Holders Change
-5
Holders Change %
-6.85%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
23
Reduced
21
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DWT
26
Dorsey & Whitney Trust
South Dakota
$72K
Morgan Stanley
27
Morgan Stanley
New York
$72K +$31.7K +35,497 +61%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$55K +$5K +5,598 +8%
AllianceBernstein
29
AllianceBernstein
Tennessee
$53K -$19.5K -21,840 -24%
TA
30
Teachers Advisors
New York
$52K
BWP
31
BSW Wealth Partners
Colorado
$50K
TA
32
Teton Advisors
New York
$50K +$13.4K +15,000 +30%
OAM
33
Oxford Asset Management
United Kingdom
$45K -$25.6K -28,583 -33%
LPL Financial
34
LPL Financial
California
$38K
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$26K
Wells Fargo
36
Wells Fargo
California
$25K -$48.9K -54,671 -62%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$25K -$27.4K -30,664 -48%
AIG
38
American International Group
New York
$23K +$5.01K +5,599 +22%
UBS Group
39
UBS Group
Switzerland
$22K +$26.3K +29,398 New
Citadel Advisors
40
Citadel Advisors
Florida
$20K -$11.9K -13,325 -33%
SRAM
41
Stone Ridge Asset Management
New York
$20K +$23.7K +26,489 New
RJA
42
Raymond James & Associates
Florida
$19K
PIA
43
Phoenix Investment Adviser
New York
$18K -$145K -162,666 -87%
State Board of Administration of Florida Retirement System
44
State Board of Administration of Florida Retirement System
Florida
$14K
VOYA Investment Management
45
VOYA Investment Management
Georgia
$14K
Principal Financial Group
46
Principal Financial Group
Iowa
$14K +$4.96K +5,549 +45%
CSS
47
Cubist Systematic Strategies
Connecticut
$13K
Balyasny Asset Management
48
Balyasny Asset Management
Illinois
$12K -$13.1K -14,705 -49%
Wolverine Trading
49
Wolverine Trading
Illinois
$12K +$336 +376 +2%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$12K +$9.59K +10,728 +181%

GEN Hedge Fund Activity: Q4 2017 in Review

68 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q4 2017, worth a combined $22.6M — down 33% from $33.8M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of GEN and 8 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 23 added.

The largest buyer was Prescott Group Capital Management, opening a new position worth an estimated $2.02M. The largest seller was Columbia Pacific Advisors, cutting an estimated $1.1M.

  • 68 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q4 2017, down from 73 in Q3 2017.
  • Funds reported $22.6M of Genesis Healthcare, Inc. stock for Q4 2017, down 33% quarter-over-quarter.
  • 8 funds opened new Genesis Healthcare, Inc. positions in Q4 2017 and 13 closed out, a net change of -5 holders.
  • The largest Genesis Healthcare, Inc. buyer in Q4 2017 was Prescott Group Capital Management, an estimated $2.02M added.
  • The largest Genesis Healthcare, Inc. seller in Q4 2017 was Columbia Pacific Advisors, an estimated $1.1M sold.

Based on aggregated 13F filings for Q4 2017.